Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
02/2008
02/13/2008EP1335747B1 A composition of sodium channel blocking compound
02/13/2008EP1168934B1 Hydrogel-forming system with hydrophobic and hydrophilic components
02/13/2008EP1105467B9 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES
02/13/2008CN201019903Y Shoulder thermotherapy shirt
02/13/2008CN101124318A Novel strain conferring anti-disease properties to host and bacterial cell composition
02/13/2008CN101124229A Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
02/13/2008CN101124227A Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity
02/13/2008CN101124220A 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
02/13/2008CN101124213A Sulfonyl amino cyclic derivatives and use thereof as mmp inhibitors
02/13/2008CN101124203A Chemical compounds
02/13/2008CN101121749A Gamma-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
02/13/2008CN101121017A Traditional Chinese medicine formula for cleaning moisture and dispelling cold
02/13/2008CN101120982A Traditional Chinese medicine for treating rheumatism and hyperosteogeny
02/13/2008CN101120981A Traditional Chinese medicine preparation for treating fracture and wound and pain and preparation process thereof
02/13/2008CN101120933A Transdermal paster containing bulleyaconitine A and its preparation method
02/13/2008CN101120932A External applied preparation for etodolac
02/13/2008CN101120915A Dexamethasone sodium phosphate injection
02/13/2008CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders
02/13/2008CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
02/13/2008CN100368374C Carboxylic compound and medicine comprising the same
02/13/2008CN100368008C Chinese medicine for treating gynopathy and its preparing process
02/13/2008CN100368002C An externally applied analgetic and preparation method thereof
02/13/2008CN100367973C Drying material and producing method thereof
02/13/2008CN100367955C Compsn. of medication of containing creat lactone of triacetyl and usages
02/13/2008CN100367953C Quercetin solid liposome nano particle preparation and its preparing method
02/13/2008CN100367946C Gabapentin analogues for fibromy algia and other disorders
02/13/2008CN100367930C Spontaneously dispersible N-benzoyl staurosporine compositions
02/13/2008CN100367929C Preparation of Chinese traditional medicine for curing female inflammation and preparation method
02/12/2008US7329777 Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis
02/12/2008US7329764 Substitute benzothiophene compounds
02/12/2008US7329761 Substituted imides
02/12/2008US7329755 especially naphthalene sulfonamides, used for treating asthma
02/12/2008US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
02/12/2008US7329749 Piperazinylcarbonylquinolines and -isoquinolines
02/12/2008US7329689 Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester
02/12/2008US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain
02/12/2008US7329681 Inhibitors of IMPDH enzyme
02/12/2008US7329677 2-[3-(4-Methoxypyridin-2-yl)prop-2-yl]-3H-imidazo[4,5-b]pyridine hydrochloride; transcriptional activation of the iNOS-promoter, tissue and organ damage, cytotoxicity reduction
02/12/2008US7329675 Substituted azabicyclic compounds
02/12/2008US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
02/12/2008US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
02/12/2008US7329667 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor
02/12/2008US7329660 Phthalazine derivatives for treating inflammatory diseases
02/12/2008US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors
02/12/2008US7329651 Cannabimimetic ligands
02/12/2008US7329507 Linking oligopeptide to a stabilizing group, linking the oligopeptide to a therapeutic agent, testing if the conjugate is cleavable by Thimet oligopeptidase
02/12/2008US7329423 Compositions comprising thylakoids useful in the modulation of inflammation process
02/12/2008US7329422 Treating breast or liver cancer with a concentrate formed by extracting rhizomes of Fagopyrum dibotrys (golden buckwheat) with alcohol and concentrating the extract to a powder or syrup, optionally followed by fractionation.
02/12/2008US7329409 Immunology response intensifiers; administering a bacterial lysate, for inducing an immune response to Staphylococcus aureus infections
02/12/2008US7329406 Methods of treating psoriasis with αvβ3-specific antibodies
02/12/2008CA2387018C Chemokine receptor
02/12/2008CA2367909C Use of lipoxin compounds for inhibiting of tnf-(alpha) initiated neutrophil response
02/12/2008CA2315532C Cyclopeptide derivatives with integrin inhibitor properties
02/12/2008CA2303432C Modulation of drug loading in multivesicular liposomes
02/12/2008CA2234716C Peptides for treatment of inflammation and shock
02/12/2008CA2202137C Composition, device and method for enhanced electrotransport agent delivery
02/12/2008CA2133982C Ligand for the c-kit receptor and methods of use thereof
02/07/2008WO2008016675A1 P38 kinase inhibitors
02/07/2008WO2008016661A2 Morpholino compounds for treating inflammatory and demyelinating diseases and cancers
02/07/2008WO2008016175A1 Activator for peroxisome proliferator activated receptor
02/07/2008WO2008016131A1 Fused heterocyclic compound
02/07/2008WO2008016118A1 Agent targeting dopamine receptor and screening method therefor
02/07/2008WO2008016077A1 Adhesive preparation
02/07/2008WO2008016006A1 Compound having cyclic group bound thereto through spiro binding and use thereof
02/07/2008WO2008015538A2 Use of diaza- and thiaza-cycloalkanediones for preventing and/or treating pain and /or migraine
02/07/2008WO2008015335A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
02/07/2008WO2008015163A1 Treatment of pain
02/07/2008WO2008014822A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
02/07/2008WO2008014821A1 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors
02/07/2008WO2008014815A1 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents
02/07/2008WO2008000777A3 Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use
02/07/2008WO2007140385A3 Thiazole compounds as cannabinoid receptor ligands and uses thereof
02/07/2008WO2007135505A3 Veterinary pharmaceutical compositions for the treatment of pain and inflammation
02/07/2008WO2007117778A3 Quinolones useful as inducible nitric oxide synthase inhibitors
02/07/2008WO2006105304A8 Phenyl and pyridyl lta4h modulators
02/07/2008US20080033170 Novel compounds
02/07/2008US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders
02/07/2008US20080033038 Compositions of polyphenols and methods of use
02/07/2008US20080033033 8-azaprostaglandin derivatives and medical use thereof
02/07/2008US20080033024 Aryl amino acid derivatives as inhibitors for treating inflammation
02/07/2008US20080033013 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation
02/07/2008US20080033008 Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
02/07/2008US20080032991 2, 8-disubstituted Naphthyridine Derivatives
02/07/2008US20080032986 Benzyl amines, a process for their production and their use as anti-inflammatory agents
02/07/2008US20080032983 Ortho-Substituted N'-Benzylidene-(3-Hydroxyphenyl)Acethydrazides
02/07/2008US20080032981 Aryl n-cyanoguanidines and methods related thereto
02/07/2008US20080032978 Soluble epoxide hydrolase inhibitors
02/07/2008US20080032969 Novel compounds
02/07/2008US20080032967 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase
02/07/2008US20080032956 2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds
02/07/2008US20080032922 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression
02/07/2008US20080032915 Cysteine Rich Peptides for Improving Thiol Homeostasis
02/07/2008US20080032336 Chemokine receptor materials and methods
02/07/2008US20080031951 Compositions and methods for the inhibition of phospholipase A2
02/07/2008US20080031885 Use of Goat Serum for Veterinary Treatment
02/07/2008US20080031875 Treatment method
02/07/2008US20080031835 Antiinflammatory And Analgesic Preparation For External Use
02/07/2008DE102006036326A1 Dendritische Polyglycerolsulfate und -sulfonate und deren Verwendung bei entzündlichen Erkrankungen Dendritic polyglycerol sulfates and sulfonates and the use thereof in inflammatory diseases
02/07/2008CA2659696A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
02/07/2008CA2659693A1 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors